Hepatocellular Carcinoma Clinical Trials in Taoyuan District
7 recruitingTaoyuan District, Taiwan
Showing 1–7 of 7 trials
Recruiting
Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
Biliary Tract CancerHepatocellular Carcinoma
AstraZeneca294 enrolled60 locationsNCT05775159
Recruiting
Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 3
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular Carcinoma
Hepatocellular CarcinomaAdvanced Hepatocellular Carcinoma
Polaris Group300 enrolled11 locationsNCT05317819
Recruiting
Phase 1Phase 2
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
AstraZeneca304 enrolled20 locationsNCT06795022
Recruiting
Phase 2
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
Hepatocellular Carcinoma
Lukas Biomedical Inc.95 enrolled13 locationsNCT05304481
Recruiting
Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 Cm and Microvascular Invasion
Hepatocellular Carcinoma (HCC)Solitary Mass
Chang Gung Memorial Hospital3,000 enrolled1 locationNCT06628661
Recruiting
Phase 2
Phase 2 Study of ADI-PEG 20 Plus Lenvatinib Treatment in Subjects With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma
Chang Gung Memorial Hospital120 enrolled1 locationNCT06034977